These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24785096)

  • 1. Breast cancer prognosis predicted by nuclear receptor-coregulator networks.
    Doan TB; Eriksson NA; Graham D; Funder JW; Simpson ER; Kuczek ES; Clyne C; Leedman PJ; Tilley WD; Fuller PJ; Muscat GE; Clarke CL
    Mol Oncol; 2014 Jul; 8(5):998-1013. PubMed ID: 24785096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research resource: nuclear receptors as transcriptome: discriminant and prognostic value in breast cancer.
    Muscat GE; Eriksson NA; Byth K; Loi S; Graham D; Jindal S; Davis MJ; Clyne C; Funder JW; Simpson ER; Ragan MA; Kuczek E; Fuller PJ; Tilley WD; Leedman PJ; Clarke CL
    Mol Endocrinol; 2013 Feb; 27(2):350-65. PubMed ID: 23292282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptor expression defines a set of prognostic biomarkers for lung cancer.
    Jeong Y; Xie Y; Xiao G; Behrens C; Girard L; Wistuba II; Minna JD; Mangelsdorf DJ
    PLoS Med; 2010 Dec; 7(12):e1000378. PubMed ID: 21179495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis.
    Han SJ; O'Malley BW
    Hum Reprod Update; 2014; 20(4):467-84. PubMed ID: 24634322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling of 3696 Nuclear Receptor-Coregulator Interactions: A Resource for Biological and Clinical Discovery.
    Broekema MF; Hollman DAA; Koppen A; van den Ham HJ; Melchers D; Pijnenburg D; Ruijtenbeek R; van Mil SWC; Houtman R; Kalkhoven E
    Endocrinology; 2018 Jun; 159(6):2397-2407. PubMed ID: 29718163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The orphan nuclear receptor LRH-1 and ERα activate GREB1 expression to induce breast cancer cell proliferation.
    Chand AL; Wijayakumara DD; Knower KC; Herridge KA; Howard TL; Lazarus KA; Clyne CD
    PLoS One; 2012; 7(2):e31593. PubMed ID: 22359603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer.
    Lin ML; Patel H; Remenyi J; Banerji CR; Lai CF; Periyasamy M; Lombardo Y; Busonero C; Ottaviani S; Passey A; Quinlan PR; Purdie CA; Jordan LB; Thompson AM; Finn RS; Rueda OM; Caldas C; Gil J; Coombes RC; Fuller-Pace FV; Teschendorff AE; Buluwela L; Ali S
    Oncotarget; 2015 Aug; 6(25):21685-703. PubMed ID: 26280373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.
    Girault I; Lerebours F; Amarir S; Tozlu S; Tubiana-Hulin M; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Apr; 9(4):1259-66. PubMed ID: 12684393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct nuclear receptor expression in stroma adjacent to breast tumors.
    Knower KC; Chand AL; Eriksson N; Takagi K; Miki Y; Sasano H; Visvader JE; Lindeman GJ; Funder JW; Fuller PJ; Simpson ER; Tilley WD; Leedman PJ; Graham J; Muscat GE; Clarke CL; Clyne CD
    Breast Cancer Res Treat; 2013 Nov; 142(1):211-23. PubMed ID: 24122391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-specific patterns of coregulator requirements by estrogen receptor-α in breast cancer cells.
    Won Jeong K; Chodankar R; Purcell DJ; Bittencourt D; Stallcup MR
    Mol Endocrinol; 2012 Jun; 26(6):955-66. PubMed ID: 22543272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes and functions from breast cancer signatures.
    Huang S; Murphy L; Xu W
    BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Tumor initiating cell-enriched prognostic signature for HER2+:ERα- breast cancer; rationale, new features, controversies and future directions.
    Liu JC; Egan SE; Zacksenhaus E
    Oncotarget; 2013 Aug; 4(8):1317-28. PubMed ID: 23945331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers.
    Yau C; Benz CC
    Breast Cancer Res; 2008; 10(4):R61. PubMed ID: 18631401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
    Liu D
    Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
    Madak-Erdogan Z; Katzenellenbogen BS
    Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.
    Liu JC; Voisin V; Bader GD; Deng T; Pusztai L; Symmans WF; Esteva FJ; Egan SE; Zacksenhaus E
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5832-7. PubMed ID: 22460789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERα- breast cancer.
    Liu JC; Zacksenhouse M; Eisen A; Nofech-Mozes S; Zacksenhaus E
    PLoS One; 2017; 12(6):e0179223. PubMed ID: 28632792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
    Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
    Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.
    West DC; Kocherginsky M; Tonsing-Carter EY; Dolcen DN; Hosfield DJ; Lastra RR; Sinnwell JP; Thompson KJ; Bowie KR; Harkless RV; Skor MN; Pierce CF; Styke SC; Kim CR; de Wet L; Greene GL; Boughey JC; Goetz MP; Kalari KR; Wang L; Fleming GF; Györffy B; Conzen SD
    Clin Cancer Res; 2018 Jul; 24(14):3433-3446. PubMed ID: 29636357
    [No Abstract]   [Full Text] [Related]  

  • 20. Pan-cancer analyses of human nuclear receptors reveal transcriptome diversity and prognostic value across cancer types.
    Parris TZ
    Sci Rep; 2020 Feb; 10(1):1873. PubMed ID: 32024906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.